Prestige Consumer Healthcare Inc. PBH is likely to post an increase in the bottom line when it reports first-quarter fiscal 2021 results on Aug 6. The Zacks Consensus Estimate for first-quarter earnings has remained unchanged at 70 cents per share in the past 30 days. The estimate suggests an increase of 7.7% from the year-ago quarter’s reported figure. This healthcare product provider has a trailing four-quarter earnings surprise of 6.3%, on average.
However, the company’s top line is expected to decline year over year. The consensus mark for revenues is pegged at $221.9 million that indicates decline of 4.4% from the figure reported in the year-ago quarter.
Prestige Consumer Healthcare Inc. Price and EPS Surprise
Key Factors to Note
The company's e-commerce investments have been yielding results. During fourth-quarter fiscal 2020, online business improved more than 60%, given consumers’ shift to online shopping amid the coronavirus outbreak. Continuation of such trends bodes well for the quarter under review. Moreover, the company has been undertaking robust cost curtailments amid the pandemic. Apart from these, the company has been benefiting from its transformation efforts and a strong focus on the healthcare business. Markedly, management expects earnings per share of 70 cents or more in the first quarter of fiscal 2021.
In its lastearnings call management stated that it expects to see some reversal in the coronavirus-led stockpiling trends in the first quarter that was witnessed in the fourth quarter. The company anticipates this reduction to have had an adverse impact on retailer orders to an extent in the to-be-reported quarter. Also, volatile foreign currency movements are a concern. Notably, management expects revenues of nearly $220 million in the fiscal first quarter.
What the Zacks Model Unveils
Our proven model doesn’t conclusively predict an earnings beat for Prestige Consumer this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Prestige Consumer carries a Zacks Rank #3 and an Earnings ESP of 0.00%.
Stocks With Favorable Combination
Here are some companies that you may want to consider as our model shows that these have the right combination of elements to post an earnings beat.
Crocs CROX has an Earnings ESP of +45.16% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Deckers DECK has an Earnings ESP of +6.60% and a Zacks Rank of 1.
Skechers SKX has an Earnings ESP of +6.10% and a Zacks Rank #3.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Skechers U.S.A., Inc. (SKX): Free Stock Analysis Report
Deckers Outdoor Corporation (DECK): Free Stock Analysis Report
Prestige Consumer Healthcare Inc. (PBH): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.